Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Impact of psychological profile on drug adherence and drug resistance in patients with apparently treatment-resistant hypertension.

Petit G, Berra E, Georges CMG, Capron A, Huang QF, Lopez-Sublet M, Rabbia F, Staessen JA, Wallemacq P, de Timary P, Persu A.

Blood Press. 2018 Dec;27(6):358-367. doi: 10.1080/08037051.2018.1476058. Epub 2018 Jun 28.

PMID:
29952236
2.

Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.

Verstraete AG, Rigo-Bonnin R, Wallemacq P, Vogeser M, Schuetzenmeister A, Schmiedel C, Shipkova M.

Ther Drug Monit. 2018 Feb;40(1):59-68. doi: 10.1097/FTD.0000000000000474.

PMID:
29210975
3.

Measurement of sirolimus concentrations in human blood using an automated electrochemiluminescence immunoassay (ECLIA): a multicenter evaluation.

Stove V, Ramos PA, Wallemacq P, Vogeser M, Schuetzenmeister A, Schmiedel C, Shipkova M.

Clin Chem Lab Med. 2018 Apr 25;56(5):764-775. doi: 10.1515/cclm-2017-0583.

PMID:
29206642
4.

Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients.

Percy C, Hassoun Z, Mourad M, De Meyer M, Beguin C, Jadoul M, Goffin E, Wallemacq P, Kanaan N.

Transplant Proc. 2017 Nov;49(9):2065-2069. doi: 10.1016/j.transproceed.2017.09.019.

PMID:
29149962
5.

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

Delattre IK, Taccone FS, Jacobs F, Hites M, Dugernier T, Spapen H, Laterre PF, Wallemacq PE, Van Bambeke F, Tulkens PM.

Expert Rev Anti Infect Ther. 2017 Jul;15(7):677-688. doi: 10.1080/14787210.2017.1338139. Epub 2017 Jun 19.

PMID:
28571493
6.

Enteric hyperoxaluria in chronic pancreatitis.

Demoulin N, Issa Z, Crott R, Morelle J, Danse E, Wallemacq P, Jadoul M, Deprez PH.

Medicine (Baltimore). 2017 May;96(19):e6758. doi: 10.1097/MD.0000000000006758.

7.

The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study.

Van Obbergh F, Knoops L, Devos T, Beguin Y, Graux C, Benghiat F, Kargar-Samani K, Bauwens D, Efira A, Dubois C, Springael C, Montfort L, Connerotte T, Capron A, Delannoy A, Wallemacq P.

Clin Biochem. 2017 May;50(7-8):452-454. doi: 10.1016/j.clinbiochem.2016.12.006. Epub 2016 Dec 22.

8.

Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study.

Smeets M, Degryse J, Janssens S, Matheï C, Wallemacq P, Vanoverschelde JL, Aertgeerts B, Vaes B.

BMJ Open. 2016 Oct 6;6(10):e012888. doi: 10.1136/bmjopen-2016-012888.

9.

Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.

Tré-Hardy M, Capron A, Antunes MV, Linden R, Wallemacq P.

Clin Biochem. 2016 Nov;49(16-17):1295-1298. doi: 10.1016/j.clinbiochem.2016.07.018. Epub 2016 Aug 3.

PMID:
27498307
10.

Cyclosporine A disposition, hepatic and renal tolerance in Wistar rat.

Maerckx C, Lombard CA, Tondreau T, Najimi M, Wallemacq P, Sokal EM.

Immunopharmacol Immunotoxicol. 2016 Sep 27:1-5. [Epub ahead of print]

PMID:
27600635
11.

Mass spectrometry in laboratory medicine: High-tech now meeting the needs of routine laboratory testing.

Wallemacq P.

Clin Biochem. 2016 Sep;49(13-14):945-6. doi: 10.1016/j.clinbiochem.2016.08.001. Epub 2016 Aug 9. No abstract available.

PMID:
27520545
12.

Intra-cellular immunosuppressive drugs monitoring: A step forward towards better therapeutic efficacy after organ transplantation?

Capron A, Haufroid V, Wallemacq P.

Pharmacol Res. 2016 Sep;111:610-618. doi: 10.1016/j.phrs.2016.07.027. Epub 2016 Jul 25. Review.

PMID:
27468645
13.

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension.

Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, Staessen JA, Wallemacq P, Persu A.

Hypertension. 2016 Aug;68(2):297-306. doi: 10.1161/HYPERTENSIONAHA.116.07464. Epub 2016 Jun 13. Review. No abstract available.

PMID:
27296995
14.

Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study.

De Meyer M, Haufroid V, Kanaan N, Darius T, Buemi A, De Pauw L, Eddour DC, Wallemacq P, Mourad M.

Pharmacogenomics. 2016 Jun;17(9):1019-27. doi: 10.2217/pgs-2016-0005. Epub 2016 Jun 8.

PMID:
27266721
15.

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee.

Seger C, Shipkova M, Christians U, Billaud EM, Wang P, Holt DW, Brunet M, Kunicki PK, Pawiński T, Langman LJ, Marquet P, Oellerich M, Wieland E, Wallemacq P.

Ther Drug Monit. 2016 Apr;38(2):170-89. doi: 10.1097/FTD.0000000000000269. Review.

PMID:
26982493
16.

Therapeutic Drug Monitoring of Everolimus: A Consensus Report.

Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, Brunet M, Budde K, Barten MJ, De Simone P, Wieland E, López OM, Masuda S, Seger C, Picard N, Oellerich M, Langman LJ, Wallemacq P, Morris RG, Thompson C, Marquet P.

Ther Drug Monit. 2016 Apr;38(2):143-69. doi: 10.1097/FTD.0000000000000260.

PMID:
26982492
17.

Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.

Brunet M, Shipkova M, van Gelder T, Wieland E, Sommerer C, Budde K, Haufroid V, Christians U, López-Hoyos M, Barten MJ, Bergan S, Picard N, Millán López O, Marquet P, Hesselink DA, Noceti O, Pawinski T, Wallemacq P, Oellerich M.

Ther Drug Monit. 2016 Apr;38 Suppl 1:S1-20. doi: 10.1097/FTD.0000000000000287. Review.

PMID:
26977997
18.

First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemia.

Capron A, Antunes MV, Wagner SC, Mattevi VS, Vieira N, Leite R, Reginato F, Capra M, Fogliatto L, Wallemacq P, Linden R.

Clin Chim Acta. 2016 Jan 30;453:42-7. doi: 10.1016/j.cca.2015.11.032. Epub 2015 Dec 3.

PMID:
26657979
19.

Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs.

Picard N, Bergan S, Marquet P, van Gelder T, Wallemacq P, Hesselink DA, Haufroid V.

Ther Drug Monit. 2016 Apr;38 Suppl 1:S57-69. doi: 10.1097/FTD.0000000000000255. Review.

PMID:
26469711
20.

Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs.

Christians U, Vinks AA, Langman LJ, Clarke W, Wallemacq P, van Gelder T, Renjen V, Marquet P, Meyer EJ.

Ther Drug Monit. 2015 Dec;37(6):718-24. doi: 10.1097/FTD.0000000000000205.

PMID:
26291980
21.

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice.

Dhooghe B, Bouckaert C, Capron A, Wallemacq P, Leal T, Noel S.

Biol Open. 2015 Jun 19;4(7):929-36. doi: 10.1242/bio.010967.

22.

Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study.

Adriaensen W, Matheï C, Vaes B, van Pottelbergh G, Wallemacq P, Degryse JM.

Exp Gerontol. 2015 Sep;69:53-61. doi: 10.1016/j.exger.2015.06.005. Epub 2015 Jun 4.

PMID:
26051931
23.

Application of the characteristic function to evaluate and compare analytical variability in an external quality assessment scheme for serum ethanol.

Coucke W, Charlier C, Lambert W, Martens F, Neels H, Tytgat J, Van de Walle P, Vanescote A, Wallemacq P, Wille S, Verstraete AG.

Clin Chem. 2015 Jul;61(7):948-54. doi: 10.1373/clinchem.2015.240176. Epub 2015 May 19.

24.

General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL study.

Smeets M, Degryse J, Aertgeerts B, Janssens S, Adriaensen W, Matheï C, Van Pottelbergh G, Wallemacq P, Vanoverschelde JL, Vaes B.

Int J Cardiol. 2015 Jul 15;191:120-7. doi: 10.1016/j.ijcard.2015.05.002. Epub 2015 May 5.

PMID:
25984896
25.

CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen.

Antunes MV, de Oliveira V, Raymundo S, Staudt DE, Gössling G, Biazús JV, Cavalheiro JA, Rosa DD, Mathy G, Wallemacq P, Linden R, Schwartsmann G, Haufroid V.

Pharmacogenomics. 2015;16(6):601-17. doi: 10.2217/pgs.15.13. Epub 2015 Apr 20.

PMID:
25893704
26.

Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation.

Antunes MV, Timm TA, de Oliveira V, Staudt DE, Raymundo S, Gössling G, Biazús JV, Cavalheiro JA, Rosa DD, Wallemacq P, Haufroid V, Linden R, Schwartsmann G.

Ther Drug Monit. 2015 Dec;37(6):733-44. doi: 10.1097/FTD.0000000000000212.

PMID:
25853922
27.

How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme.

Delattre IK, Van de Walle P, Van Campenhout C, Neels H, Verstraete AG, Wallemacq P.

Clin Biochem. 2015 Jun;48(9):617-21. doi: 10.1016/j.clinbiochem.2015.03.009. Epub 2015 Mar 25.

PMID:
25818475
28.

Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study.

Douxfils J, Chatelain B, Hjemdahl P, Devalet B, Sennesael AL, Wallemacq P, Rönquist-Nii Y, Pohanka A, Dogné JM, Mullier F.

Thromb Res. 2015 May;135(5):852-60. doi: 10.1016/j.thromres.2015.02.020. Epub 2015 Feb 26.

PMID:
25743887
29.

Validation of a HPLC-MS/MS assay for the determination of total and unbound concentration of temocillin in human serum.

Ngougni Pokem P, Miranda Bastos AC, Tulkens PM, Wallemacq P, Van Bambeke F, Capron A.

Clin Biochem. 2015 May;48(7-8):542-5. doi: 10.1016/j.clinbiochem.2015.02.006. Epub 2015 Feb 21.

PMID:
25712752
30.

Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.

Thi MT, Mourad M, Capron A, Tshinanu FM, Vincent MF, Wallemacq P.

Clin Biochem. 2015 Apr;48(6):401-5. doi: 10.1016/j.clinbiochem.2014.12.005. Epub 2014 Dec 16.

PMID:
25523299
31.

Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.

Antunes MV, Raymundo S, de Oliveira V, Staudt DE, Gössling G, Peteffi GP, Biazús JV, Cavalheiro JA, Tre-Hardy M, Capron A, Haufroid V, Wallemacq P, Schwartsmann G, Linden R.

Talanta. 2015 Jan;132:775-84. doi: 10.1016/j.talanta.2014.10.040. Epub 2014 Oct 29.

32.

Interleukin-6 predicts short-term global functional decline in the oldest old: results from the BELFRAIL study.

Adriaensen W, Matheï C, Vaes B, van Pottelbergh G, Wallemacq P, Degryse JM.

Age (Dordr). 2014;36(6):9723. doi: 10.1007/s11357-014-9723-3. Epub 2014 Nov 21.

33.

Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.

Frippiat F, Musuamba FT, Seidel L, Albert A, Denooz R, Charlier C, Van Bambeke F, Wallemacq P, Descy J, Lambermont B, Layios N, Damas P, Moutschen M.

J Antimicrob Chemother. 2015 Jan;70(1):207-16. doi: 10.1093/jac/dku354. Epub 2014 Sep 12.

PMID:
25216821
34.

Prevalence of microalbuminuria and diagnostic value of dipstick proteinuria in outpatients from HIV clinics in Bukavu, the Democratic Republic of Congo.

Masimango MI, Sumaili EK, Jadoul M, Wallemacq P, Mubagwa DK, Makulo RJ, Lepira FB, Nseka NM.

BMC Nephrol. 2014 Sep 5;15:146. doi: 10.1186/1471-2369-15-146.

35.

Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.

Guy-Viterbo V, Baudet H, Elens L, Haufroid V, Lacaille F, Girard M, Debray D, Chardot C, Reding R, Wallemacq P, Musuamba F.

Pharmacogenomics. 2014 Jun;15(9):1207-21. doi: 10.2217/pgs.14.75.

PMID:
25141896
36.

No relation between CMV infection and mortality in the oldest old: results from the Belfrail study.

Matheï C, Adriaensen W, Vaes B, Van Pottelbergh G, Wallemacq P, Degryse J.

Age Ageing. 2015 Jan;44(1):130-5. doi: 10.1093/ageing/afu094. Epub 2014 Jul 15.

PMID:
25026957
37.

Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?

Buemi A, Musuamba F, Frederic S, Douhet A, De Meyer M, De Pauw L, Darius T, Kanaan N, Wallemacq P, Mourad M.

Clin Biochem. 2014 Oct;47(15):68-72. doi: 10.1016/j.clinbiochem.2014.06.079. Epub 2014 Jul 8.

PMID:
25011070
38.

Could trisialotransferrin be used as an additional biomarker to CDT in order to improve detection of chronic excessive alcohol intake?

Tamigniau A, Wallemacq P, Maisin D.

Clin Biochem. 2014 Sep;47(13-14):1203-8. doi: 10.1016/j.clinbiochem.2014.05.052. Epub 2014 May 23.

PMID:
24863961
39.

Multi-center analytical evaluation of a novel automated tacrolimus immunoassay.

Shipkova M, Vogeser M, Ramos PA, Verstraete AG, Orth M, Schneider C, Wallemacq P.

Clin Biochem. 2014 Aug;47(12):1069-77. doi: 10.1016/j.clinbiochem.2014.03.023. Epub 2014 Apr 12.

40.

Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine.

Vogeser M, Shipkova M, Rigo-Bonnin R, Wallemacq P, Orth M, Widmann M, Verstraete AG.

Ther Drug Monit. 2014 Oct;36(5):640-50. doi: 10.1097/FTD.0000000000000068.

41.

The glomerular filtration rate estimated by new and old equations as a predictor of important outcomes in elderly patients.

Van Pottelbergh G, Vaes B, Adriaensen W, Matheï C, Legrand D, Wallemacq P, Degryse JM.

BMC Med. 2014 Feb 12;12:27. doi: 10.1186/1741-7015-12-27.

42.

Drug prescriptions unadapted to the renal function in patients aged 80 years and older.

Van Pottelbergh G, Mertens A, Azermai M, Vaes B, Adriaensen W, Matheï C, Wallemacq P, Degryse JM.

Eur J Gen Pract. 2014 Sep;20(3):190-5. doi: 10.3109/13814788.2013.857399. Epub 2013 Nov 28.

PMID:
24286117
43.

Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.

Musuamba FT, Guy-Viterbo V, Reding R, Verbeeck RK, Wallemacq P.

Ther Drug Monit. 2014 Feb;36(1):54-61. doi: 10.1097/FTD.0b013e31829dcbcd.

PMID:
24081207
44.

Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry.

Nguyen Thi MT, Capron A, Mourad M, Wallemacq P.

Clin Biochem. 2013 Dec;46(18):1909-11. doi: 10.1016/j.clinbiochem.2013.09.009. Epub 2013 Sep 21.

PMID:
24060731
45.

Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.

Elens L, Capron A, van Schaik RH, De Meyer M, De Pauw L, Eddour DC, Latinne D, Wallemacq P, Mourad M, Haufroid V.

Ther Drug Monit. 2013 Oct;35(5):608-16. doi: 10.1097/FTD.0b013e318296045b.

PMID:
24052064
46.

High prevalence of thyroid dysfunction among pregnant women in Lubumbashi, Democratic Republic of Congo.

Habimana L, Twite KE, Daumerie C, Wallemacq P, Donnen P, Kalenga MK, Robert A.

Thyroid. 2014 Mar;24(3):568-75. doi: 10.1089/thy.2013.0261. Epub 2013 Oct 30.

47.

Validation of a rapid liquid chromatography-tandem mass spectrometric assay for the determination of octreotide plasma concentrations.

Capron A, Destree J, Maiter D, Wallemacq P.

Clin Biochem. 2014 Jan;47(1-2):139-41. doi: 10.1016/j.clinbiochem.2013.07.009. Epub 2013 Jul 18.

PMID:
23872204
48.

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.

Douxfils J, Tamigniau A, Chatelain B, Chatelain C, Wallemacq P, Dogné JM, Mullier F.

Thromb Haemost. 2013 Oct;110(4):723-31. doi: 10.1160/TH13-04-0274. Epub 2013 Jul 11.

PMID:
23846172
49.

The relationship between grip strength and muscle mass (MM), inflammatory biomarkers and physical performance in community-dwelling very old persons.

Legrand D, Adriaensen W, Vaes B, Matheï C, Wallemacq P, Degryse J.

Arch Gerontol Geriatr. 2013 Nov-Dec;57(3):345-51. doi: 10.1016/j.archger.2013.06.003. Epub 2013 Jul 4.

PMID:
23830056
50.

Significance of serum immune markers in identification of global functional impairment in the oldest old: cross-sectional results from the BELFRAIL study.

Adriaensen W, Matheï C, van Pottelbergh G, Vaes B, Legrand D, Wallemacq P, Degryse JM.

Age (Dordr). 2014 Feb;36(1):457-67. doi: 10.1007/s11357-013-9558-3. Epub 2013 Jul 3.

Supplemental Content

Loading ...
Support Center